Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients

Journal of Perinatology

Volumn 32, Issue 6, 2012, Pages 460-465

  Cooper, S ^a   Lange, I ^a   Wood, S ^a   Tang, S ^a   Miller, L ^a   Ross, S ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

diagnostic accuracy; fetal fibronectin; phosphorylated insulin like growth factor binding protein 1; preterm delivery

Indexed keywords

FIBRONECTIN; SOMATOMEDIN BINDING PROTEIN 1;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PREMATURE LABOR; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; VAGINAL DELIVERY;

EID: 84861816100     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.133     Document Type: Article

References (26)

1. Slattery M, Morrison J. Preterm delivery. Lancet 2002; 360(9344): 1489-1497.
2. Gilbert WM, Nesbitt TS, Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 2003; 102(3): 488-492.
3. Mistry H, Dowie R, Franklin RC, Jani BR. Costs of neonatal care for low-birthweight babies in English hospitals. Acta Paediatr 2009; 98(7): 1123-1129.
4. Leitich H, Brunbauer M, Kaider A, Egarter C, Husslein P. Cervical length and dilatation of the internal cervical detected by vaginal ultrasonography as markers for preterm delivery: a systematic review. J Obstet Gynecol 1999; 181: 1465-1472.
5. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325(7359): 301-310.
6. Rutanen EM. Insulin-like growth factors in obstetrics. Curr Opin Obstet Gynecol 2000; 12: 163-168.
7. Goldbenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020-1037.
8. Akercan F, Kazandi M, Sendag F, Cirpan T, Mgoyi L, Terek MC et al. Value of cervical phosphorylated insulinlike growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med 2004; 49: 368-372.
9. Elizur SE, Yinon Y, Epstein GS, Seidman DS, SchiV E, Sivan E. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol 2005; 22: 305-309.
10. Kwek K, Khi C, Ting HS, Yeo GS. Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singapore 2004; 33: 780-783.
11. Lembet A, Eroglu D, Ergin T, Kuscu E, Zeyneloglu H, Batioglu S et al. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions. Acta Obstet Gynecol Scand 2002; 81: 706-712.
12. Ting H-S, Chin PS, Yeo G, Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore 2007; 36: 399-402.
13. Beck B, Wojdyla D, Say L, Pilar Betran A, Merialdi M, Harris Requejo J et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organization 2010; 88: 31-38.
14. Altinkaya O, Gungor T, Ozat M, Danisman N, Mollamahmutoglu L. Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery. Arch Gynecol Obstet 2009; 279: 279-283.
15. Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J. et al. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labor. J Obstet Gynaecol Can 2010; 32(4): 307-312.
16. Azlin M, Bang H, An L, Mohamad A, Mansor N, Yee B et al. Role of phIGFBP-1 and ultrasound cervical length in predicting pre-term labor. J Obstet Gynaecol 2010; 30: 456-460.
17. Brik M, Hernandez A, Pedraz C, Perales A. Phosphorylated insulin-like growth factor binding protein-1 and cervical measurement in women with threatening preterm birth. Acta Obstet Gynecol Scand 2010; 89: 268-274.
18. Eroglu D, Yanik F, Oktem M, Zeyneloglu HB, Kuscu E. Prediction of preterm delivery among women with threatened preterm labor. Gynecol Obstet Invest 2007; 64: 109-116.
19. Paternoster D, Muresan D, Vitulo A, Serena A, Battaglirin G, Dell'Avanzo M et al. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstet Gynecol Scand 2007; 86: 151-155.
20. Rahkonen L, Unkila-Kallio L, Nuutila M, Sainio S, Saisto T, Rutanen EM et al. Cervical length measurement and cervical phosphorylated insulin-like growth factor binding protein-1 testing in prediction of preterm birth in patients reporting uterine contractions. Acta Obstet Gynecol Scand 2009; 88(8): 901-908.
21. Tanir HM, Sener T, Yildiz Z. Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes. J Obstet Gynaecol Res 2009; 35(1): 66-72.
22. Sanchez-Ramos L, Delke I, Zamora J, Kaunitz A. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients, a meta-analysis. Obstet Gynecol 2009; 114: 631-640.
23. Kornelsen J, Grzybowski S. Is local maternity care an optional service in rural communities? J Obstet Gynaecol Can 2005; 27(4): 329-331.
24. Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behaviour and health care costs? A randomized trial. Am J Obstet Gynecol 2004; 191: 235-240.
25. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008; (4): CD006843.
26. Vis JY, Wilms FF, Oudijk MA, Bossuyt PM, van der Post JA, Grobman WA et al. Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designs. Am J Perinatol 2011; 28(2): 145-150.